Morbidity and mortality from cirrhosis are substantial and increasing. Health disparities in cirrhosis and liver transplantation are reflective of inequities along the entire spectrum of chronic liver disease care, from screening and diagnosis to prevention and treatment of liver-related complications. The key populations experiencing disparities in health status and healthcare delivery include racial and ethnic minority groups, sexual and gender minorities, people of lower socioeconomic status and underserved rural communities. These disparities lead to delayed diagnosis of chronic liver disease and complications of cirrhosis (for example, hepatocellular carcinoma), to differences in treatment of chronic liver disease and its complications, and ultimately to unequal access to transplantation for those with end-stage liver disease. Calling out these disparities is only the first step towards implementing solutions that can improve health equity and clinical outcomes for everyone. Multi-level interventions along the care continuum for chronic liver disease are needed to mitigate these disparities and provide equitable access to care.

肝硬化的发病率和死亡率很高，并且还在增加。肝硬化和肝移植方面的健康差异反映了从筛查和诊断到肝脏相关并发症的预防和治疗，整个慢性肝病护理范围内的不平等。在健康状况和医疗保健服务方面存在差异的关键人群包括种族和民族少数群体、性和性别少数群体、社会经济地位较低的人和服务不足的农村社区。这些差异导致慢性肝病和肝硬化并发症（例如肝细胞癌）的诊断延迟，慢性肝病及其并发症的治疗差异，并最终导致终末期肝病患者获得移植的机会不平等。指出这些差异只是实施可以改善每个人的健康公平和临床结果的解决方案的第一步。需要沿着慢性肝病护理连续体的多层次干预措施来减轻这些差异并提供公平的护理机会。